Skip to main content

Table 3 Difference in protein expression between tumours from 5-year overall survivors and tumours from deceased patients

From: Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray

  Dead patients Alive patients   
Protein Protein expression positive (%) Protein expression negative (%) Protein expression positive (%) Protein expression negative (%) not available (No of samples) P-value dead vs. alive patients
AdipoR1 26 74 17 83 3 0.29
Adora1 30 70 23 77 8 0.47
BTG2 61 39 82 18 6 0.026*
-membrane only 19 81 44 56 6 0.013*
-cytoplasm only 52 48 68 32 6 0.14
CD46 16 84 14 86 4 0.77
  1. P-values were calculated using a two-tailed Fisher's exact test. The samples designated as not available had few tumour cells, large tissue loss or affluence of necrotic tissue.